CompuMed revenues edge up in Q3

Bone densitometry and medical informatics firm CompuMed booked fiscal third-quarter revenues of $463,000, up 8% compared with the $428,000 turned in during the third quarter last year. For the period (end-June 30), the Los Angeles-based firm had a net loss of $40,000, compared with a net loss of $48,000 in the third quarter of fiscal 2003.

In the quarter, CompuMed increased sales of its core OsteoGram and CardioGram systems, said CEO Jerry McLaughlin. The company has integrated OsteoGram into platforms from several medical imaging manufacturers, and is negotiating additional licensing agreements, he said. CompuMed said it also continues its strategy to develop and market the DICOM version of OsteoGram.

By staff writers
August 16, 2004

Related Reading

Berman joins CompuMed board, August 4, 2004

CompuMed adds distributors in Europe, Middle East, July 27, 2004

CompuMed nets California prison contract, July 20, 2004

CompuMed selects Schiller for ECG platform, July 13, 2004

CompuMed Q2 revenues slip, May 17, 2004

Copyright © 2004

Page 1 of 374
Next Page